Ann and Robert H Lurie Childrens Hospital of Chicago | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)	central nervous system disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy	Recruiting	Phase 3	2026-08-18		NCT07221669
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, congenital myasthenic syndrome, hereditary disease, nervous system disorder, neuromuscular disease, neuromuscular junction disease	Active, not recruiting	Phase 1	2026-07-24		NCT06436742
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers	Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus	Recruiting	Not applicable	2026-05-29		NCT06709755
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia	Acid-Base Imbalance, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, acidosis disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, propionic acidemia	Recruiting	Phase 1 / Phase 2	2026-01-22		NCT04159103
Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study	Pathological Conditions, Signs and Symptoms, Respiratory Sounds, Signs and Symptoms, Signs and Symptoms, Respiratory, Wheezing	Recruiting	Phase 2	2025-11-21		NCT05667701